Adhesion molecules and diabetes mellitus;Molecole di adesione e malattia diabetica

Clinica Terapeutica

Volumn 161, Issue SUPPL.1, 2011, Pages

  Urso, C ^a   Hopps, E ^a   Caimi, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Adhesion molecules; Atheroslerosis; Diabetes mellitus; Inflammation; Leukocyte; Oxidative stress

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; L SELECTIN; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; CELL ADHESION MOLECULE;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING DISORDER; BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC PATIENT; DYSLIPIDEMIA; ENDOTHELIUM; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; IMMUNE SYSTEM; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY DISEASE; LEUKOCYTE MIGRATION; NEUTROPHIL CHEMOTAXIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN FUNCTION; RETINOPATHY; ANIMAL; BLOOD; CLASSIFICATION; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CELL ADHESION MOLECULES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS;

EID: 80051796726     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Wagner OF, Jilma B. Putative role of adhesion molecules in metabolic disorders. Horm Metab Res 1997; 29(12):627-30
2. Gearing AJK, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14:506-12
3. Rothlein R, Mainolfi EA, Czajkowski M, et al. A forum of circulating ICAM-1 in human serum. J Immunol 2002; 147(11):3788-93
4. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991; 338:83
5. Budnik A, Grewe M, Gyufko K, et al. Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hematol 1996; 24:352.
6. Wakatsuki T, Kimura K, Kimura F. A distinct mRNA encoding a soluble form of ICAM-1 molecule expressed in human tissue. Cell Adhes Commun 1995; 3:283
7. Champagne B, Tremblay P, Cantin A, et al. Proteolytic cleavage of ICAM-1 by human neutrophil elastase. J Immunol 1998; 161:639
8. Devaraj S, Glaser N, Griffen S, et al. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 2006; 55:774-9
9. Jager A, Van Hinsbergh VW, Kostense PJ, et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the HOORN study. Diabetes 2000; 49(3):485-91
10. Becker A, Van Hinsbergh VW, Jager A, et al. Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality? Eur J Clin Invest 2002; 32(1):1-8
11. Otsuki M, Hashimoto K, Morimoto Y, et al. Ciculating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes 1997; 46(12):2096-101
12. Damnjanović G, Jelić M, Dindić B, et al. Serum concentration of soluble adhesive molecules in patients with different forms of coronary artery disease. Vojnosanit Pregl 2009; 66(4):265-70
13. Khaleghi M, Ali Z, Mosley TH Jr, et al. Association of soluble cell adhesion molecules with ankle-brachial index in a biethnic cohort of predominantly hypertensive individuals. Clin Chem 2008; 54(11):1788-95
14. Umemura T, Kawamura T, Sakakibara T, et al. Association of soluble adhesion molecule and C-reactive protein levels with silent brain infarction in patients with and without type 2 diabetes. Curr Neurovasc Res 2008; 5(2):106-11
15. Kawamura T, Umemura T, Kanai A, et al. The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: association with serum-soluble adhesion molecules. Diabetologia 1998; 41(8):911-7
16. Pradhan AD, Rifai N, Ridker PM. Soluble intracellular adhesion molecule-1, soluble vascular adhesion and the development of symptomatic peripheral arterial disease in men. Circulation 2002; 106:820-5
17. Gómez JM, Vila R, Catalina P, et al. The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives. Glycoconj J 2008; 25(6):573-9
18. Martin S. Soluble adhesion molecules in type 1 diabetes mellitus. Horm Metab Res 1997; 29(12):639-42
19. Toivonen AM, Kimpimäki T, Kupila A, et al. Soluble adhesion molecules in young children with signs of beta-cell autoimmunity prospective follow-up from birth. Diabetes Metab Res Rev 2006; 22(3):176-8
20. Toivonen A, Kulmala P, Rahko J, et al. Soluble adhesion molecules in Finnish schoolchildren with signs of preclinical type 1 diabetes. Diabetes Metab Res Rev 2004; 20(1):48-54
21. Toivonen A, Kulmala P, Savola K, et al. Soluble adhesion molecules in preclinical type 1 diabetes. The Childhood Diabetes in Finland Study Group. Pediatr Res 2001; 49(1):24-9
22. Toivonen AM, Kulmala P, Savola K, et al. Soluble adhesion molecules in pre-clinical Type 1 diabetes: a prospective study. Diabetologia 2003;46(4):492-5
23. Lampeter ER, Kishimoto TK, Rothlein R, et al. Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. Diabetes 1992; 41:1668-71
24. Myśliwiec J, Kretowski A, Kinalski M, et al. CD11a expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects. Immunol Lett 1999; 70(1):69-72
25. Roep BO, Hedenthal E, De Vries R, et al. Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet 1994; 343:1590-93
26. Martin S, Heidenthal E, Schulte B, et al.Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes. Diabetologia 1998; 41(11):1298-303
27. Herold KC, Vezys V, Gage A, et al. Prevention of autoimmune diabetes by treatment with anti-LFA-1 and anti-ICAM-1 monoclonal antibodies. Cell Immunol 1994; 157(2):489-500
28. Schram MT, Chaturvedi N, Schalkwijk C, et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2003; 26(7):2165-73
29. Cheung AT, Tomic MM, Chen PC, et al. Correlation of microvascular abnormalities and endothelial dysfunction in Type-1 Diabetes Mellitus (T1DM): a real-time intravital microscopy study. Clin Hemorheol Microcirc 2009; 42(4):285-95
30. Mohamed-Ali V, Armstrong L, Clarke D, et al. Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetes. J Intern Med 2001; 250(5):415-21
31. Jilma B, Fasching P, Ruthner C, et al. Elevated circulating p-selectine in insulin dependent diabetes mellitus. Thromb Haemost 1996; 76(3):328-32
32. Kopp HP, Hopmeier P, Schernthaner G. Concentrations of circulating P-selectin are increased in patients with newly diagnosed insulin-dependent diabetes mellitus. Exp Clin Endocrinol Diabetes 1998; 106:41-44
33. Bavbek N, Kargili A, Kaftan O, et al. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy? Clin Appl Thromb Hemost 2007; 13(4):391-7
34. Olson JA, WhitelawCM, McHardy KC, et al. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetol 1997; 40:1166-71
35. Doǧruel N, Kirel B, Akgün Y, et al. Serum soluble endothelial-cell specific adhesion molecules in children with insulin-dependent diabetes mellitus. J Pediatr Endocrinol Metab 2001; 14(3):287-93
36. Nowak M, Wielkoszyński T, Marek B, et al. Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy. Clin Exp Med 2008; 8(3):159-64
37. Clausen P, Jacobsen P, Rossing K, et al. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet Med 2000; 17(9):644-9
38. Soedamah-Muthu SS, Chaturvedi N, Schalkwijk CG, et al. EURODIAB Prospective Complications Study group. Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients. J Diabetes Complications 2006; 20(3):188-95
39. Sokup A. Adhesion molecules in type 2 diabetes. Przegl Lek 2005; 62(4):234-7
40. Fasching P. Elevated circulating adhesion molecules in NIDDM - potential mediators in diabetic macroangiopathy. Diabetol 1996; 39:1242-4
41. Song Y, Manson JE, Tinker L, et al. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes 2007; 56(7):1898-904
42. Kado S, Nagata N. Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus. Diab Res Clin Pract 1999; 46:143-8
43. Bannan S, Mansfield MW, Grant PJ. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetol 1998; 41(4):460-6
44. Steiner M, Reinhardt KM, Krammer B, et al. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 1994; 72(6):979-84
45. Cominacini L, Fratta Pasini A, Garbin U, et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetol 1995; 38:1122-4
46. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation and products in tissue and the biochemical basis of diabetic complications. NewEngl J Med 1998; 318:1315-21
47. Fasching P, Veitl M, Rohac M, et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-development diabetes mellitus. J Clin Endocrinol Metab 1996; 81:4313-7
48. Blann, Maxwell Waite. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertension 1994; 12:925-8
49. Boulbou MS, Koukoulis GN, Makri ED, et al. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int J Cardiol 2005; 98(1):39-44
50. Rubio-Guerra AF, Vargas-Robles H, Medina-Santillán R, et al. Levels of soluble adhesion molecules among normal and hypertensive type 2 diabetic patients. Gac Med Mex 2008; 144(1):11-4
51. Cominacini L. Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL. Diabetol 1996; 39:1244
52. Rubin D, Claas S, Pfeuffer M, et al. s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, becoming evident in the postprandial response to a lipid-rich meal. Lipids Health Dis 2008; 7:32
53. Murakami H, Tamasawa N, Matsui J, et al. Plasma levels of soluble vascular adhesion molecule-1 and cholesterol oxidation product in type 2 diabetic patients with nephropathy. J Atheroscler Thromb 2001; 8(1):21-4
54. Rubio-Guerra AF, Vargas-Robles H, Ayala GV, et al. Correlation between circulating adhesion molecule levels and albuminuria in type 2 diabetic normotensive patients. Med Sci Monit 2007; 13(8):349-52
55. Wong CK, Ho AW, Tong PC, et al. Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy. J Clin Immunol 2008; 28(1):36-43
56. De Angelis L, Marfella MA, Siniscalchi M, et al. Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia 2001; 44(9):1155-60
57. Newman W, Beall LD, Carson CW, et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993; 150:644-54
58. Albertini JP, Valensi P, Lormeau B, et al. Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients. Diabetes Care 1999; 22:2044-8
59. Albertini JP, Valensi P, Lormeau B, et al. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Diabetes Care 1998; 21(6):1008-13
60. Ryysy L, Yki-Järvinen H. Improvement of glycemic control by 1 year of insulin therapy leads to a sustained decrease in sE-selectin concentrations in type 2 diabetes. Diabetes Care 2001; 24(3):549-54
61. Ceriello A, Falletti E, Bortolotti N, et al. Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism 1996; 45:498-501
62. Khan BV, Parthasarathy S, Alexander RW, et al. Modified lowdensity lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995; 95:1262-70
63. Cominacini L, Fratta Pasini A, Garbin U, et al. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress. Diabetol 1997; 40:584-9
64. Devaraj S, Jialai I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications. Circulation 2000; 102:191-6
65. Bursell SE, Clearmont AC, Aiello LP. High dose AT supplementation normalizes retinal blood flowand creatinine clearance in patients with type I diabetes. Diabetes Care 1999; 22:1245-51
66. Skyrme-Jones P, AndrewR, Meredith T. Soluble adhesion molecules, endothelial function and vitamin E in type 1 diabetes. Coron Artery Dis 2001; 12:69-75
67. De Mattia G, Bravi MC, Laurenti O, et al. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes. Diabetol 1998; 41(11):1392-6
68. Matsumoto K, Miyake S, Yano M, et al. High serum concentrations of soluble E-selectin in patients with impaired glucose tolerance with hyperinsulinemia. Atherosclerosis 2000; 152:415-20
69. Bluher M, Unger R, Rassoul F, et al. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type II diabetes. Diabetol 2002; 45(2):210-6
70. Marfella R, Esposito K, Giunta R, et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 2000; 101(19):2247-51
71. Cominacini L, Garbin U, Pasini AF. Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients. Diabetes 1998; 47:130-3
72. Targher G, Bonadonna RC, Alberiche M, et al. Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. Diabetes Care 2001; 24(11):1961-6
73. Glowinska B, Urban M, Peczynska J, et al. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 2005; 54(8):1020-6
74. Okapcova J. The levels of soluble adhesion molecules in diabetic and non diabetic patients with combined hyperlipoproteinemia and the effect of ciprofibrate therapy. Angiol 2004; 55(6):629-39
75. Lopes-Virella MF, Mironova M, Durazo-Arvizu R, et al. Role of simvastatin as an immunomodulator in type 2 diabetes. Diabetes Care 2004; 27:908-13
76. Hogue JC, Lamarche B, Tremblay AJ, et al. Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus. Metabolism 2008; 57(3):380-6
77. Kent JW, Comizzie AG, Mahaney MC et al. Intercellular adhesion molecule-1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in mexican americans. Diabetes 2004; 53:2691-5
78. Hsu LA, Ko YL, Wu S, et al. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese. Metabolism 2009; 58(7):983-8
79. Takeuchi N, Kawamura T, Kanai A, et al. The effect of cigarette smoking on soluble adhesion molecules in middle-aged patients with Type 2 diabetes mellitus. Diabet Med 2002; 19(1):57-64
80. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009; 94(9):3171-82
81. Blann AD, Lip GYH. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus. Diabet Med 1998; 15:634-42